Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients. - Xu, Jianming; Cui, Jiuwei; Jiang, Haiping; Zeng, Yan; Cong, Xiuyu (Cancer Medicine, 2023)